Stefanie Jackson
Nurse Practitioner · Lake City, FLNPI 1346204427
Payments from drug & device makers
Across 279 payments — averaging $15.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Amgen$326
- Pfizer$278
- Johnson & Johnson$275
- Novartis$256
- Lilly USA, LLC$233
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,235100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 102 | $1,320 |
| Amgen | 20 | $326 |
| Pfizer | 14 | $278 |
| Johnson & Johnson | 23 | $275 |
| Novartis | 18 | $256 |
| Lilly USA, LLC | 13 | $233 |
| Merck | 10 | $166 |
| Bayer | 9 | $138 |
| AbbVie | 7 | $136 |
| Exact Sciences | 8 | $131 |
| GSK | 8 | $131 |
| Mylan Specialty L.p. | 5 | $98 |
| Teva Pharmaceuticals USA, Inc. | 6 | $86 |
| Edwards Lifesciences | 2 | $72 |
| Esperion Therapeutics, Inc. | 4 | $68 |
| Sanofi-aventis U.S. LLC | 4 | $58 |
| Biogen | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Phathom Pharmaceuticals, Inc. | 2 | $44 |
| Astellas Pharma US Inc | 2 | $40 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| AstraZeneca | 2 | $27 |
| BD | 1 | $27 |
| Lundbeck LLC | 1 | $24 |
| Nestle Healthcare Nutrition Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Boston Scientific | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Dexcom, Inc. | 1 | $13 |
| Corcept Therapeutics | 1 | $13 |
How this compares
$4,235 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 73 | $113,610 |
| EliquisApixaban | 99 | $102,090 |
| FarxigaDapagliflozin Propanediol | 76 | $79,645 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 31 | $46,943 |
| RybelsusSemaglutide | 14 | $34,065 |
| JardianceEmpagliflozin | 23 | $32,846 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 28 | $32,719 |
| TrulicityDulaglutide | 14 | $29,108 |
| Repatha SureclickEvolocumab | 35 | $28,788 |
| EntrestoSacubitril/Valsartan | 15 | $27,750 |
| Tresiba Flextouch U-200Insulin Degludec | 21 | $21,684 |
| XareltoRivaroxaban | 16 | $18,664 |
| JanuviaSitagliptin Phosphate | 20 | $18,628 |
| Lagevrio (Eua)Molnupiravir | 12 | $6,423 |
| Calcium Acetate | 46 | $3,300 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,320 | $147,67587 claims |
| PfizerEliquis | $278 | $102,09099 claims |
| AstraZenecaFarxiga | $27 | $79,64576 claims |
| GSKTrelegy Ellipta | $131 | $46,94331 claims |
| Boehringer IngelheimJardiance | $15 | $32,84623 claims |
| Lilly USA, LLCTrulicity | $233 | $29,10814 claims |
| NovartisEntresto | $256 | $27,75015 claims |
| MerckJanuvia, Lagevrio (Eua) | $166 | $25,05132 claims |
| Johnson & JohnsonXarelto | $275 | $18,66416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Lake City
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.